Angeline Gacad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Angeline Gacad has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Maura M. Kepper
Prevention Research Center, Brown School, Washington University in St. Louis, St. Louis, MO, United States
3 shared publications - Callie Walsh-Bailey
Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, USA
2 shared publications - Cynthia Herrick
Department of Internal Medicine, Division of Endocrinology, Diabetes, and Lipid Metabolism Research, Washington University in St. Louis
2 shared publications - Kianna Zucker
Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, 675 18th Street, San Francisco, CA, 94143, USA
2 shared publications - Min Zhao
Institute for Informatics, Data Science, and Biostatistics, Washington University School of Medicine , St. Louis, MO 63110
2 shared publications - Neil H. White
Division of Pediatric Endocrinology & Diabetes, Washington University School of Medicine, St. Louis, MO, United States
2 shared publications
Latest Publications
- Open Access
- 4 November 2026
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 5, e101509
AI-Enabled Digital Health Tool Implementation in Clinical Practice Settings: Umbrella Review
Background: AI has the potential to improve clinical decision-making, efficiency, and patient outcomes, yet adoption in routine clinical practice has been slower than anticipated. While prior studies have identified factors that influence AI implementation, a comprehensive synthesis grounded in implementation science frameworks is lacking. Objective: This study aimed to qualitatively and comprehensively describe barriers and facilitators to AI implementation in clinical care settings using an implementation science determinants framework, the Consolidated Framework for Implementation Research (CFIR), and to identify AI-specific determinants not fully captured by CFIR. Methods: We conducted an umbrella review of reviews examining determinants of AI implementation in clinical practice. In accordance with the PRIOR (Preferred Reporting Items for Overviews of Reviews) reporting guidance, we systematically searched PubMed, Scopus, and CINAHL for English-language reviews published between January 2013 and July 2025. Reviews were included if they addressed barriers to and facilitators of implementing AI-enabled digital health tools in clinical care settings. Determinants were deductively mapped to the updated CFIR and inductively analyzed to identify emergent AI-specific constructs. Review quality was assessed using the Joanna Briggs Institute critical appraisal checklist, and overlap among primary studies was evaluated using the GROOVE (Graphical Representation of Overlap for Overviews) tool. Results: Twenty-two reviews published between 2021 and 2025 were included, encompassing studies conducted from 1990 to 2025. Reviews varied in design, including systematic, scoping, rapid, narrative, and literature reviews. Overall review quality was mixed, with 9 (41%) reviews rated at 100% quality and 4 (18%) at 50% or lower. Primary study overlap was slight, with a corrected covered area of 0.4%. Determinants of AI implementation were identified across all CFIR domains. Prominent barriers at the innovation level included limited evidence of clinical impact, poor interpretability, complexity, lack of adaptability, and insufficiently representative data. Facilitators included perceived relative advantage, co-design with clinicians, and evidence of local clinical benefit. At the implementer level, low AI literacy, limited confidence, time constraints, and concerns about professional displacement were common barriers, while training and technical support facilitated adoption. Inner setting barriers included inadequate infrastructure, limited resources, poor workflow compatibility, and weak governance structures. Outer setting barriers included unclear policies, laws, and liability frameworks, whereas partnerships and cross-sector collaboration were frequent facilitators. Inductively identified AI-specific determinants included transparency, trust, accountability, model bias, data governance, model maintenance, robustness, generalizability, existential threat, and concern about loss of the human element in care. Conclusions: AI implementation in clinical settings is shaped by complex, multilevel, and AI-specific determinants that extend beyond traditional digital health considerations. Implementation science frameworks can be adapted to incorporate these constructs. Tailored, theory-informed strategies addressing technical, organizational, psychological, and regulatory factors are essential to support safe, equitable, and sustainable integration of AI into clinical care.
- 4 November 2026
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 5, e101509
Open AccessAI-Enabled Digital Health Tool Implementation in Clinical Practice Settings: Umbrella Review
Background: AI has the potential to improve clinical decision-making, efficiency, and patient outcomes, yet adoption in routine clinical practice has been slower than anticipated. While prior studies have identified factors that influence AI implementation, a comprehensive synthesis grounded in implementation science frameworks is lacking. Objective: This study aimed to qualitatively and comprehensively describe barriers and facilitators to AI implementation in clinical care settings using an implementation science determinants framework, the Consolidated Framework for Implementation Research (CFIR), and to identify AI-specific determinants not fully captured by CFIR. Methods: We conducted an umbrella review of reviews examining determinants of AI implementation in clinical practice. In accordance with the PRIOR (Preferred Reporting Items for Overviews of Reviews) reporting guidance, we systematically searched PubMed, Scopus, and CINAHL for English-language reviews published between January 2013 and July 2025. Reviews were included if they addressed barriers to and facilitators of implementing AI-enabled digital health tools in clinical care settings. Determinants were deductively mapped to the updated CFIR and inductively analyzed to identify emergent AI-specific constructs. Review quality was assessed using the Joanna Briggs Institute critical appraisal checklist, and overlap among primary studies was evaluated using the GROOVE (Graphical Representation of Overlap for Overviews) tool. Results: Twenty-two reviews published between 2021 and 2025 were included, encompassing studies conducted from 1990 to 2025. Reviews varied in design, including systematic, scoping, rapid, narrative, and literature reviews. Overall review quality was mixed, with 9 (41%) reviews rated at 100% quality and 4 (18%) at 50% or lower. Primary study overlap was slight, with a corrected covered area of 0.4%. Determinants of AI implementation were identified across all CFIR domains. Prominent barriers at the innovation level included limited evidence of clinical impact, poor interpretability, complexity, lack of adaptability, and insufficiently representative data. Facilitators included perceived relative advantage, co-design with clinicians, and evidence of local clinical benefit. At the implementer level, low AI literacy, limited confidence, time constraints, and concerns about professional displacement were common barriers, while training and technical support facilitated adoption. Inner setting barriers included inadequate infrastructure, limited resources, poor workflow compatibility, and weak governance structures. Outer setting barriers included unclear policies, laws, and liability frameworks, whereas partnerships and cross-sector collaboration were frequent facilitators. Inductively identified AI-specific determinants included transparency, trust, accountability, model bias, data governance, model maintenance, robustness, generalizability, existential threat, and concern about loss of the human element in care. Conclusions: AI implementation in clinical settings is shaped by complex, multilevel, and AI-specific determinants that extend beyond traditional digital health considerations. Implementation science frameworks can be adapted to incorporate these constructs. Tailored, theory-informed strategies addressing technical, organizational, psychological, and regulatory factors are essential to support safe, equitable, and sustainable integration of AI into clinical care.
- Open Access
- 17 May 2024
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 8, e55731
The Impact of Behavior Change Counseling Delivered via a Digital Health Tool Versus Routine Care Among Adolescents With Obesity: Pilot Randomized Feasibility Study
Background: Youth overweight and obesity is a public health crisis and increases the risk of poor cardiovascular health (CVH) and chronic disease. Health care providers play a key role in weight management, yet few tools exist to support providers in delivering tailored evidence-based behavior change interventions to patients. Objective: The goal of this pilot randomized feasibility study was to determine the feasibility of implementing the Patient-Centered Real-Time Intervention (PREVENT) tool in clinical settings, generate implementation data to inform scale-up, and gather preliminary effectiveness data. Methods: A pilot randomized clinical trial was conducted to examine the feasibility, implementation, and preliminary impact of PREVENT on patient knowledge, motivation, behaviors, and CVH outcomes. The study took place in a multidisciplinary obesity management clinic at a children’s hospital within an academic medical center. A total of 36 patients aged 12 to 18 years were randomized to use PREVENT during their routine visit (n=18, 50%) or usual care control (n=18, 50%). PREVENT is a digital health tool designed for use by providers to engage patients in behavior change education and goal setting and provides resources to support change. Patient electronic health record and self-report behavior data were collected at baseline and 3 months after the intervention. Implementation data were collected via PREVENT, direct observation, surveys, and interviews. We conducted quantitative, qualitative, and mixed methods analyses to evaluate pretest-posttest patient changes and implementation data. Results: PREVENT was feasible, acceptable, easy to understand, and helpful to patients. Although not statistically significant, only PREVENT patients increased their motivation to change their behaviors as well as their knowledge of ways to improve heart health and of resources. Compared to the control group, PREVENT patients significantly improved their overall CVH and blood pressure (P<.05). Conclusions: Digital tools can support the delivery of behavior change counseling in clinical settings to increase knowledge and motivate patients to change their behaviors. An appropriately powered trial is necessary to determine the impact of PREVENT on CVH behaviors and outcomes. Trial Registration: ClinicalTrials.gov NCT06121193; https://www.clinicaltrials.gov/study/NCT06121193
- 17 May 2024
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 8, e55731
Open AccessThe Impact of Behavior Change Counseling Delivered via a Digital Health Tool Versus Routine Care Among Adolescents With Obesity: Pilot Randomized Feasibility Study
Background: Youth overweight and obesity is a public health crisis and increases the risk of poor cardiovascular health (CVH) and chronic disease. Health care providers play a key role in weight management, yet few tools exist to support providers in delivering tailored evidence-based behavior change interventions to patients. Objective: The goal of this pilot randomized feasibility study was to determine the feasibility of implementing the Patient-Centered Real-Time Intervention (PREVENT) tool in clinical settings, generate implementation data to inform scale-up, and gather preliminary effectiveness data. Methods: A pilot randomized clinical trial was conducted to examine the feasibility, implementation, and preliminary impact of PREVENT on patient knowledge, motivation, behaviors, and CVH outcomes. The study took place in a multidisciplinary obesity management clinic at a children’s hospital within an academic medical center. A total of 36 patients aged 12 to 18 years were randomized to use PREVENT during their routine visit (n=18, 50%) or usual care control (n=18, 50%). PREVENT is a digital health tool designed for use by providers to engage patients in behavior change education and goal setting and provides resources to support change. Patient electronic health record and self-report behavior data were collected at baseline and 3 months after the intervention. Implementation data were collected via PREVENT, direct observation, surveys, and interviews. We conducted quantitative, qualitative, and mixed methods analyses to evaluate pretest-posttest patient changes and implementation data. Results: PREVENT was feasible, acceptable, easy to understand, and helpful to patients. Although not statistically significant, only PREVENT patients increased their motivation to change their behaviors as well as their knowledge of ways to improve heart health and of resources. Compared to the control group, PREVENT patients significantly improved their overall CVH and blood pressure (P<.05). Conclusions: Digital tools can support the delivery of behavior change counseling in clinical settings to increase knowledge and motivate patients to change their behaviors. An appropriately powered trial is necessary to determine the impact of PREVENT on CVH behaviors and outcomes. Trial Registration: ClinicalTrials.gov NCT06121193; https://www.clinicaltrials.gov/study/NCT06121193
- Open Access
- 21 December 2023
- Published by JMIR Publications Inc. in JMIR Preprints
The Impact of Behavior Change Counseling Delivered via a Digital Health Tool Versus Routine Care Among Adolescents With Obesity: Pilot Randomized Feasibility Study (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Youth overweight and obesity is a public health crisis and increases the risk of poor cardiovascular health (CVH) and chronic disease. Health care providers play a key role in weight management, yet few tools exist to support providers in delivering tailored evidence-based behavior change interventions to patients. Objective: The goal of this pilot randomized feasibility study was to determine the feasibility of implementing the Patient-Centered Real-Time Intervention (PREVENT) tool in clinical settings, generate implementation data to inform scale-up, and gather preliminary effectiveness data. Methods: A pilot randomized clinical trial was conducted to examine the feasibility, implementation, and preliminary impact of PREVENT on patient knowledge, motivation, behaviors, and CVH outcomes. The study took place in a multidisciplinary obesity management clinic at a children’s hospital within an academic medical center. A total of 36 patients aged 12 to 18 years were randomized to use PREVENT during their routine visit (n=18, 50%) or usual care control (n=18, 50%). PREVENT is a digital health tool designed for use by providers to engage patients in behavior change education and goal setting and provides resources to support change. Patient electronic health record and self-report behavior data were collected at baseline and 3 months after the intervention. Implementation data were collected via PREVENT, direct observation, surveys, and interviews. We conducted quantitative, qualitative, and mixed methods analyses to evaluate pretest-posttest patient changes and implementation data. Results: PREVENT was feasible, acceptable, easy to understand, and helpful to patients. Although not statistically significant, only PREVENT patients increased their motivation to change their behaviors as well as their knowledge of ways to improve heart health and of resources. Compared to the control group, PREVENT patients significantly improved their overall CVH and blood pressure (P<.05). Conclusions: Digital tools can support the delivery of behavior change counseling in clinical settings to increase knowledge and motivate patients to change their behaviors. An appropriately powered trial is necessary to determine the impact of PREVENT on CVH behaviors and outcomes. Trial Registration: ClinicalTrials.gov NCT06121193; https://www.clinicaltrials.gov/study/NCT06121193
- 21 December 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe Impact of Behavior Change Counseling Delivered via a Digital Health Tool Versus Routine Care Among Adolescents With Obesity: Pilot Randomized Feasibility Study (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Youth overweight and obesity is a public health crisis and increases the risk of poor cardiovascular health (CVH) and chronic disease. Health care providers play a key role in weight management, yet few tools exist to support providers in delivering tailored evidence-based behavior change interventions to patients. Objective: The goal of this pilot randomized feasibility study was to determine the feasibility of implementing the Patient-Centered Real-Time Intervention (PREVENT) tool in clinical settings, generate implementation data to inform scale-up, and gather preliminary effectiveness data. Methods: A pilot randomized clinical trial was conducted to examine the feasibility, implementation, and preliminary impact of PREVENT on patient knowledge, motivation, behaviors, and CVH outcomes. The study took place in a multidisciplinary obesity management clinic at a children’s hospital within an academic medical center. A total of 36 patients aged 12 to 18 years were randomized to use PREVENT during their routine visit (n=18, 50%) or usual care control (n=18, 50%). PREVENT is a digital health tool designed for use by providers to engage patients in behavior change education and goal setting and provides resources to support change. Patient electronic health record and self-report behavior data were collected at baseline and 3 months after the intervention. Implementation data were collected via PREVENT, direct observation, surveys, and interviews. We conducted quantitative, qualitative, and mixed methods analyses to evaluate pretest-posttest patient changes and implementation data. Results: PREVENT was feasible, acceptable, easy to understand, and helpful to patients. Although not statistically significant, only PREVENT patients increased their motivation to change their behaviors as well as their knowledge of ways to improve heart health and of resources. Compared to the control group, PREVENT patients significantly improved their overall CVH and blood pressure (P<.05). Conclusions: Digital tools can support the delivery of behavior change counseling in clinical settings to increase knowledge and motivate patients to change their behaviors. An appropriately powered trial is necessary to determine the impact of PREVENT on CVH behaviors and outcomes. Trial Registration: ClinicalTrials.gov NCT06121193; https://www.clinicaltrials.gov/study/NCT06121193